Dr. Niklson has a PhD in Human Development Neuroanatomy and gained extensive business experience in various leading positions before joining the Pharma industry. She was assistant professor in Clinical Physiology at the University of Novi Sad and investigator for clinical studies. She joined Organonā€™s Headquarter in The Netherlands in 1992, where she was involved in the development of antidepressants. After being the Director of the CNS Therapeutics Group at UCB, she joined F.Hoffman-La Roche Headquarter in Basel to lead the clinical development of CNS compounds and thereafter spent a short period as Medical Reviewer at Swissmedic. She is currently Scientific Officer, NSO at Novartis. Her special interest is clinical trial methodology in CNS and particularly in depression, epilepsy and Alzheimerā€™s disease.
